191 related articles for article (PubMed ID: 28883291)
1. [Evidence and topics of chemotherapy for hepatocellular carcinoma].
Ueshima K; Kudo M
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1621-1628. PubMed ID: 28883291
[No Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
O'Neil BH; Venook AP
Oncologist; 2007 Dec; 12(12):1425-32. PubMed ID: 18165619
[TBL] [Abstract][Full Text] [Related]
3. Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
Nagai H; Matsui T; Kanayama M; Wakui N; Momiyama K; Watanabe M; Igarashi Y; Sumino Y
Cancer Chemother Pharmacol; 2011 Jul; 68(1):139-45. PubMed ID: 20857114
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intermediate-stage hepatocellular carcinoma.
Finn RS
Clin Adv Hematol Oncol; 2015 Aug; 13(8):501-3. PubMed ID: 26351811
[No Abstract] [Full Text] [Related]
5. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapy of hepatocellular carcinoma: current and promising.
Kalyan A; Nimeiri H; Kulik L
Clin Liver Dis; 2015 May; 19(2):421-32. PubMed ID: 25921671
[TBL] [Abstract][Full Text] [Related]
7. Closing remarks.
Kudo M
Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
[No Abstract] [Full Text] [Related]
8. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
[No Abstract] [Full Text] [Related]
9. Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
Chan SL; Johnson P
Asia Pac J Clin Oncol; 2012 Jun; 8(2):111-4. PubMed ID: 22524569
[No Abstract] [Full Text] [Related]
10. Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2).
Kudo M; Arizumi T
Oncology; 2017; 93 Suppl 1():127-134. PubMed ID: 29258086
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Geschwind JF; Chapiro J
Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
[No Abstract] [Full Text] [Related]
12. [A case of hepatoma effectively treated by TAE and intra-arterial and intraportal infusion chemotherapy].
Sato M; Watanabe Y; Sakai K; Iwamura F; Kimura S
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1318-24. PubMed ID: 3023506
[No Abstract] [Full Text] [Related]
13. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
Tsochatzis E; Meyer T; Marelli L; Burroughs AK
J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
[No Abstract] [Full Text] [Related]
14. Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
Yoo DJ; Kim KM; Jin YJ; Shim JH; Ko GY; Yoon HK; Sung KB; Lee JL; Kang YK; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Gastroenterol Hepatol; 2011 Jan; 26(1):145-54. PubMed ID: 21175808
[TBL] [Abstract][Full Text] [Related]
15. [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
Ikeda K; Kumada H; Arase Y; Nakamura I; Chayama K; Murashima N; Takeuchi K; Nakajima M; Yoshiba A; Irimoto M
Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2377-85. PubMed ID: 2830421
[No Abstract] [Full Text] [Related]
16. [The treatment of hepatocellular carcinoma. New developments].
Kuiken SD; van Delden OM; Richel DJ; Jansen PL
Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326
[No Abstract] [Full Text] [Related]
17. Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.
Tong H; Li X; Wei B; Tang C
Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):e65-6. PubMed ID: 25746137
[No Abstract] [Full Text] [Related]
18. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Yau T; Pang R; Chan P; Poon RT
Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatocellular carcinoma.
Giuliani F; Colucci G
Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
[TBL] [Abstract][Full Text] [Related]
20. [New therapeutic options in the treatment of hepatocellular carcinoma].
Martinotti R; Evangelista W; Goss M; Angelini F; Satolli MA
Minerva Med; 2001 Oct; 92(5):341-7. PubMed ID: 11675578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
